BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 27697592)

  • 21. Cyclin A1 is a transcriptional target of PITX2 and overexpressed in papillary thyroid carcinoma.
    Liu Y; Huang Y; Zhu GZ
    Mol Cell Biochem; 2013 Dec; 384(1-2):221-7. PubMed ID: 24002705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human bone marrow-derived stem cell proliferation is inhibited by hepatocyte growth factor via increasing the cell cycle inhibitors p53, p21 and p27.
    Chen K; Perez-Stable C; D'Ippolito G; Schiller PC; Roos BA; Howard GA
    Bone; 2011 Dec; 49(6):1194-204. PubMed ID: 21907315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death regulators.
    Cerda SR; Mustafi R; Little H; Cohen G; Khare S; Moore C; Majumder P; Bissonnette M
    Oncogene; 2006 May; 25(22):3123-38. PubMed ID: 16434969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of Pitx2 in stromal cells is required for normal hematopoiesis.
    Kieusseian A; Chagraoui J; Kerdudo C; Mangeot PE; Gage PJ; Navarro N; Izac B; Uzan G; Forget BG; Dubart-Kupperschmitt A
    Blood; 2006 Jan; 107(2):492-500. PubMed ID: 16195330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pitx2c overexpression promotes cell proliferation and arrests differentiation in myoblasts.
    Martínez-Fernandez S; Hernández-Torres F; Franco D; Lyons GE; Navarro F; Aránega AE
    Dev Dyn; 2006 Nov; 235(11):2930-9. PubMed ID: 16958127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Pitx2-MicroRNA Pathway Modulates Cell Proliferation in Myoblasts and Skeletal-Muscle Satellite Cells and Promotes Their Commitment to a Myogenic Cell Fate.
    Lozano-Velasco E; Vallejo D; Esteban FJ; Doherty C; Hernández-Torres F; Franco D; Aránega AE
    Mol Cell Biol; 2015 Sep; 35(17):2892-909. PubMed ID: 26055324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EVI1 targets ΔNp63 and upregulates the cyclin dependent kinase inhibitor p21 independent of p53 to delay cell cycle progression and cell proliferation in colon cancer cells.
    Nayak KB; Kuila N; Das Mohapatra A; Panda AK; Chakraborty S
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1568-76. PubMed ID: 23665236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The significance of PITX2 overexpression in human colorectal cancer.
    Hirose H; Ishii H; Mimori K; Tanaka F; Takemasa I; Mizushima T; Ikeda M; Yamamoto H; Sekimoto M; Doki Y; Mori M
    Ann Surg Oncol; 2011 Oct; 18(10):3005-12. PubMed ID: 21479692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein kinase C phosphorylation modulates N- and C-terminal regulatory activities of the PITX2 homeodomain protein.
    Espinoza HM; Ganga M; Vadlamudi U; Martin DM; Brooks BP; Semina EV; Murray JC; Amendt BA
    Biochemistry; 2005 Mar; 44(10):3942-54. PubMed ID: 15751970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. shRNA-mediated silencing of the RFC3 gene suppresses hepatocellular carcinoma cell proliferation.
    Yao Z; Hu K; Huang H; Xu S; Wang Q; Zhang P; Yang P; Liu B
    Int J Mol Med; 2015 Nov; 36(5):1393-9. PubMed ID: 26397132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleostemin knocking-down causes cell cycle arrest and apoptosis in human T-cell acute lymphoblastic leukemia MOLT-4 cells via p53 and p21Waf1/Cip1 up-regulation.
    Rahmati M; Moosavi MA; Zarghami N
    Hematology; 2014 Dec; 19(8):455-62. PubMed ID: 24628257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential expression and redundancy of Pitx2 and Pitx3 genes during muscle development.
    L'Honoré A; Coulon V; Marcil A; Lebel M; Lafrance-Vanasse J; Gage P; Camper S; Drouin J
    Dev Biol; 2007 Jul; 307(2):421-33. PubMed ID: 17540357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RXR antagonism induces G0 /G1 cell cycle arrest and ameliorates obesity by up-regulating the p53-p21(Cip1) pathway in adipocytes.
    Nakatsuka A; Wada J; Hida K; Hida A; Eguchi J; Teshigawara S; Murakami K; Kanzaki M; Inoue K; Terami T; Katayama A; Ogawa D; Kagechika H; Makino H
    J Pathol; 2012 Apr; 226(5):784-95. PubMed ID: 21956786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 Regulates Progenitor Cell Quiescence and Differentiation in the Airway.
    McConnell AM; Yao C; Yeckes AR; Wang Y; Selvaggio AS; Tang J; Kirsch DG; Stripp BR
    Cell Rep; 2016 Nov; 17(9):2173-2182. PubMed ID: 27880895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma.
    Dai W; Miao H; Fang S; Fang T; Chen N; Li M
    Mol Med Rep; 2016 Aug; 14(2):1509-14. PubMed ID: 27314282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.
    Wei S; Xiong M; Zhan DQ; Liang BY; Wang YY; Gutmann DH; Huang ZY; Chen XP
    Carcinogenesis; 2012 Mar; 33(3):538-47. PubMed ID: 22226916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential role of diphenyleneiodonium, a flavoenzyme inhibitor, on p53-dependent and -independent cell cycle progression.
    Song JD; Kim KM; Kim KH; Kim CD; Kim JM; Yoo YH; Park YC
    Int J Oncol; 2008 Dec; 33(6):1299-306. PubMed ID: 19020764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hes1 is required for contact inhibition of cell proliferation in 3T3-L1 preadipocytes.
    Noda N; Honma S; Ohmiya Y
    Genes Cells; 2011 Jun; 16(6):704-13. PubMed ID: 21481105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Miz-1 promotes the proliferation of esophageal cancer cells via suppression of p21 and release of p21-arrested cyclin D1.
    Luo J; Zhang C; Wang C; Li L; Li C; Li Q; Zhang M; Wu Q
    Oncol Rep; 2016 Jun; 35(6):3532-40. PubMed ID: 27109891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1.
    Lin HP; Lin CY; Huo C; Hsiao PH; Su LC; Jiang SS; Chan TM; Chang CH; Chen LT; Kung HJ; Wang HD; Chuu CP
    Oncotarget; 2015 Mar; 6(9):6684-707. PubMed ID: 25788262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.